Table 1.
Lipid and apolipoprotein parameters in non-CAD and CAD subjects
| Non-CAD (N=200) | CAD (N=90) | Pvalue | |
|---|---|---|---|
|
Men, % |
48.0 |
80.0 |
0.01 |
|
Age, yr |
53.4±10.7 |
57.4±10.9 |
0.233 |
|
Parameters (mg/dL±SEM) |
|
|
|
|
TG |
223.2±15.8 |
261.9±12.4 |
0.07 |
|
TC |
224.3±4.3 |
244.8±7.0 |
0.01 |
|
HDL-C |
42.5±0.8 |
37.0±1.2 |
0.0003 |
|
LDL-C |
165.5±4.1 |
174.6±6.7 |
0.23 |
|
ApoAI |
130.4±2.3 |
77.8±5.7 |
<0.0001 |
|
ApoB |
97.9±7.8 |
111.7±3.1 |
0.10 |
|
Lp(a) |
1.3±0.1 |
1.1±0.2 |
0.36 |
|
ApoCIII |
18.9±0.4 |
17.4±0.6 |
0.06 |
|
HDL-ApoCIII |
9.4±0.2 |
12.3±0.4 |
<0.0001 |
|
VLDL-ApoCIII |
9.9±0.3 |
5.5±0.4 |
<0.0001 |
|
ApoE |
4.2±0.1 |
5.0±0.3 |
0.05 |
|
VLDL-ApoE |
1.3±0.1 |
1.7±0.3 |
0.18 |
| HDL-ApoE | 3.0±0.1 | 3.4±0.2 | 0.07 |
Data are expressed as the mean ± standard error of the mean (SEM)
CAD = coronary artery disease; TG = triglyceride; TC = total cholesterol; HDL-C = high-density lipoprotein cholesterol; LDL-C = low-density lipoprotein cholesterol; Apo = apolipoprotein; Lp(a) = lipoprotein (a); HDL = high-density lipoprotein; VLDL = very-low-density lipoprotein.